首页> 外国专利> GASTROKINETIC BICYCLIC BENZAMIDES OF 3- OR 4-SUBSTITUTED 4-(AMINOMETHYL)-PIPERIDINE DERIVATES, PROCESS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

GASTROKINETIC BICYCLIC BENZAMIDES OF 3- OR 4-SUBSTITUTED 4-(AMINOMETHYL)-PIPERIDINE DERIVATES, PROCESS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

机译:3-或4-取代的4-(氨基甲基)-哌啶衍生物的胃肠动力学双环苯甲酰胺,其制备方法和包含它们的药物组合物

摘要

Bicyclic benzamide derivatives of 3- or 4-substituted 4-(aminomethyl)piperidine derivatives of formula (I) and their stereoisomers, N-oxides and acidic and basic addition salts are new. R1 + R2 = OCH2O, OCH2CH2O, OCH2CH2, OCH2CH2CH2, OCH2CH2CH2O or OCH2CH2CH2CH2 in which one or two H atoms are optionally substituted by 1-6C alkyl; R3 = H or halo; R4 = H or 1-6C alkyl; R5 = H or 1-6C alkyl; L = 3-6C cycloalkyl, 5-6C cycloalkanone, 2-6C alkenyl or Alk-R6, Alk-X-R7, Alk-Y-COR9 or Alk-Y-CONR11R12; Alk = 1-12C alkanediyl; R6 = H, OH, CN, 1-6C alkylsulphonylamino, 3-6C cycloalkyl, 5-6C cycloalkanone or Het1; R7 = H, 1-6C alkyl, hydroxy(1-6C alkyl), 3-6C cycloalkyl or Het2; X = O, S, SO2 or NR8; R8 = H or 1-6C alkyl; R9 = H, 1-6C alkyl, 3-6C cycloalkyl, 1-6C alkyloxy or OH; Y = NR10 or a bond; R10 = H or 1-6C alkyl; R11, R12 = H, 1-6C alkyl, 3-6C cycloalkyl or NR11R12 = pyrrolidinyl or piperidinyl (both optionally substituted by 1-6C alkyl, amino or mono- or di-(1-6C alkyl)amino) or piperazinyl or 4-morpholinyl (both optionally substituted by 1-6C alkyl); Het1, Het2 = furan (optionally substituted by 1-6C alkyl or halo) or tetrahydrofuran, dioxolane, dioxane or tetrahydropyran (all optionally substituted by 1-6C alkyl), pyrrolidinyl or pyridinyl (both optionally substituted by 1 or 2 halo, OH, CN or 1-6C alkyl); pyrimidinyl (optionally substituted by 1 or 2 halo, OH, CN, 1-6C alkyl, 1-6C alkyloxy, amino or mono- or di-(1-6C alkyl)amino), pyridazinyl (optionally substituted by 1 or 2 OH, 1-6C alkyloxy, 1-6C alkyl or halo) or pyrazinyl (optionally substituted by 1 or 2 halo, OH, CN, 1-6C alkyl, 1-6C alkyloxy, amino, mono- or di-(1-6C alkyl)amino or 1-6C alkyloxycarbonyl); Het1 can also be a group of formulae (a)-(d); Het1, Het2 can also be a group of formulae (e)-(g); R13, R14 = H or 1-4C alkyl. One compound (I) is specifically claimed i.e. trans-(-)-4-amino-5-chloro- 2,3-dihydro-N-[[3-hydroxy-1- (3-methoxypropyl)-4-piperidinyl] -methyl]-2,2-dimethyl-7- benzofurancarboxamide.
机译:式(I)的3-或4-取代的4-(氨基甲基)哌啶衍生物的双环苯甲酰胺衍生物及其立体异构体,N-氧化物以及酸性和碱性加成盐是新的。 R1 + R2 = OCH2O,OCH2CH2O,OCH2CH2,OCH2CH2CH2,OCH2CH2CH2O或OCH2CH2CH2CH2,其中一个或两个H原子可选地被1-6C烷基取代; R3 = H或卤素; R4 = H或1-6C烷基; R5 = H或1-6C烷基; L = 3-6C环烷基,5-6C环烷酮,2-6C烯基或Alk-R6,Alk-X-R7,Alk-Y-COR9或Alk-Y-CONR11R12;烷基= 1-12C烷二基; R6 = H,OH,CN,1-6C烷基磺酰基氨基,3-6C环烷基,5-6C环烷酮或Het1; R7 = H,1-6C烷基,羟基(1-6C烷基),3-6C环烷基或Het2; X = O,S,SO2或NR8; R8 = H或1-6C烷基; R9 = H,1-6C烷基,3-6C环烷基,1-6C烷氧基或OH; Y = NR10或键; R10 = H或1-6C烷基; R11,R12 = H,1-6C烷基,3-6C环烷基或NR11R12 =吡咯烷基或哌啶基(均可被1-6C烷基,氨基或单或二(1-6C烷基)氨基取代)或哌嗪基或4 -吗啉基(均任选被1-6C烷基取代); Het1,Het2 =呋喃(可被1-6C烷基或卤素取代)或四氢呋喃,二氧戊环,二恶烷或四氢吡喃(均可被1-6C烷基取代),吡咯烷基或吡啶基(均可被1或2个卤素取代,OH, CN或1-6C烷基);嘧啶基(任选被1或2个卤素,OH,CN,1-6C烷基,1-6C烷氧基,氨基或单或二(1-6C烷基)氨基取代),哒嗪基(任选被1或2 OH取代, 1-6C烷氧基,1-6C烷基或卤素)或吡嗪基(可选被1或2个卤素,OH,CN,1-6C烷基,1-6C烷氧基,氨基,单-或二-(1-6C烷基)取代氨基或1-6C烷氧基羰基); Het1也可以是一组式(a)-(d); Het1,Het2也可以是一组公式(e)-(g); R13,R14 = H或1-4C烷基。特别要求保护一种化合物(I),即反式-(-)-4-氨基-5-氯-2,3-二氢-N-[[3-羟基-1-(3-甲氧基丙基)-4-哌啶基]-甲基] -2,2-二甲基-7-苯并呋喃甲酰胺。

著录项

  • 公开/公告号HU0002539A3

    专利类型

  • 公开/公告日2002-03-28

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA N.V. BEERSE;

    申请/专利号HU20000002539

  • 发明设计人

    申请日1998-07-07

  • 分类号C07D405/12;A61K31/445;A61P1/14;C07D405/14;

  • 国家 HU

  • 入库时间 2022-08-22 00:45:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号